Will regulation help or hinder Bitcoin's price growth in the long-term?
more...
This is a discussion on Market News within the Analytics and News forums, part of the Trading Forum category; Will regulation help or hinder Bitcoin's price growth in the long-term? more......
Roche Holdings’ oncology business accounts for over 50% of the company valuation, according to our estimates. The company’s blockbuster oncology drugs are Avastin, Herceptin and MabThera/Rituxan. These three drugs alone accounted for roughly 40% of the company’s overall revenues in 2016
more...
Johnson & Johnson will report its Q3 2017 earnings on October 17, and we expect the company to post solid numbers, owing to three primary factors – a ramp up in key oncology drug sales, the Actelion acquisition, and forex gains.
more...
A new survey has found "acute pressure" confronting businesses in the U.S. and Britain to deliver apps in the digital and 'IoT' era, with half of companies canvassed admitting to releasing apps to the market before completing quality testing. Could it expose them to the app scrap heap?
more...
Iraqi and Iranian forces engaged Kurdish forces in an apparent attempt to gain control of oil fields. This could shift regional alliances and alter global oil markets.
more...
Bookmarks